Antimalarial pharmacology and therapeutics of atovaquone

GL Nixon, DM Moss, AE Shone… - Journal of …, 2013 - academic.oup.com
Atovaquone is used as a fixed-dose combination with proguanil (Malarone) for treating
children and adults with uncomplicated malaria or as chemoprophylaxis for preventing …

The cytochrome bc1 complex as an antipathogenic target

N Fisher, B Meunier, GA Biagini - Febs Letters, 2020 - Wiley Online Library
The cytochrome bc1 complex is a key component of the mitochondrial respiratory chains of
many eukaryotic microorganisms that are pathogenic for plants or humans, such as fungi …

Evidence-based clinical guidelines for immigrants and refugees

K Pottie, C Greenaway, J Feightner, V Welch… - Cmaj, 2011 - Can Med Assoc
Health: Deborah Assayag, Elizabeth Barnett, Jennifer Blake, Beverly Brockest, Giovani
Burgos, Glenn Campbell, Andrea Chambers, Angie Chan, Maryann Cheetham, Walter …

Structural analysis of atovaquone-inhibited cytochrome bc1 complex reveals the molecular basis of antimalarial drug action

D Birth, WC Kao, C Hunte - Nature communications, 2014 - nature.com
Atovaquone, a substituted hydroxynaphthoquinone, is a potent antimalarial drug that acts by
inhibiting the parasite's mitochondrial cytochrome bc 1 complex (cyt bc 1). Mutations in cyt …

Antiviral potential of the antimicrobial drug atovaquone against SARS-CoV-2 and emerging variants of concern

ME Carter-Timofte, R Arulanandam… - ACS infectious …, 2021 - ACS Publications
The antimicrobial medication malarone (atovaquone/proguanil) is used as a fixed-dose
combination for treating children and adults with uncomplicated malaria or as …

Clinical implications of Plasmodium resistance to atovaquone/proguanil: a systematic review and meta-analysis

HM Staines, R Burrow, BHY Teo… - Journal of …, 2018 - academic.oup.com
Background Atovaquone/proguanil, registered as Malarone®, is a fixed-dose combination
recommended for first-line treatment of uncomplicated Plasmodium falciparum malaria in …

Malaria chemoprophylaxis: strategies for risk groups

P Schlagenhauf, E Petersen - Clinical microbiology reviews, 2008 - Am Soc Microbiol
The risk of malaria for travelers varies from region to region and depends on the intensity of
transmission, the duration of the stay in the area of endemicity, the style of travel, and the …

Inhibitors of de novo folate enzymes in Plasmodium falciparum

A Nzila - Drug discovery today, 2006 - Elsevier
Antifolates, inhibitors of folate synthesis or folate conversion, are used for malaria treatment.
They are developed as synergistic combinations of inhibitors of dihydrofolate reductase …

Current knowledge and challenges of antimalarial drugs for treatment and prevention in pregnancy

E Sevene, R González, C Menéndez - Expert opinion on …, 2010 - Taylor & Francis
Importance of the field: Malaria infection during pregnancy is a major public health problem
worldwide, with 50 million pregnancies exposed to the infection every year. Approximately …

Adverse neuropsychiatric effects of antimalarial drugs

B Grabias, S Kumar - Expert opinion on Drug safety, 2016 - Taylor & Francis
Introduction: Antimalarial drugs are the primary weapon to treat parasite infection, save lives,
and curtail further transmission. Accumulating data have indicated that at least some …